Wanbury Limited

NSE WANBURY.NS

Wanbury Limited Market Capitalization on January 31, 2025: USD 79.96 M

Wanbury Limited Market Capitalization is USD 79.96 M on January 31, 2025, a 39.55% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Wanbury Limited 52-week high Market Capitalization is USD 121.66 M on December 17, 2024, which is 52.16% above the current Market Capitalization.
Wanbury Limited 52-week low Market Capitalization is USD 49.90 M on March 19, 2024, which is -37.59% below the current Market Capitalization.
Wanbury Limited average Market Capitalization for the last 52 weeks is USD 79.03 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NSE: WANBURY.NS

Wanbury Limited

CEO	Mr. Pradeep Patni
IPO Date	Jan. 29, 2007
Location	India
Headquarters	BSEL Tech Park, B-Wing
Employees	1,491
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Pet Food Plastics

Description

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Key trends

Past 5 years